CDK2 and hepatocellular carcinoma: Then, we dissected the fundamental mechanisms of SC-III3 fighting against hepatocellular carcinoma: SC-III3 induced ROS-mediated DNA damage, which activated S phase checkpoint through ATM-activated Chk1/2-Cdc25A-Cdk2 and p53-p21 cascade.